This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1969 and headquartered in New York, Assurant Inc. is a global provider of risk management solutions in the housing and lifestyle markets, protecting where people live and the goods they buy. The company operates in North America, Latin America, Europe and Asia Pacific. Assurant was incorporated as a Delaware corporation in 2004. The company reports through three reportable segments: Global Lifestyle, Global Housing and Global Preneed.
Can Lemonade Keep its Beat Streak Alive in Q2 Earnings?
by Zacks Equity Research
LMND eyes 33% revenue growth in Q2, banking on improved in-force premium and net investment income.
Heritage Due to Report Q2 Earnings: Here's What to Expect
by Zacks Equity Research
HRTG eyes a 68.8% earnings jump in Q2 but a 0.00% Earnings ESP clouds the possibility of the continuation of the insurer's streak of beats.
Is a Beat in the Cards for Assurant This Earnings Season?
by Zacks Equity Research
AIZ's second-quarter earnings are likely to have benefited from Homeowners' top-line growth and global mobile device protection growth in Connected Living.
EverQuote Set to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
EVER eyes 34% revenue growth and a 106% EPS jump in Q2, fueled by market recovery and platform-driven demand gains.
Will Palomar Holdings Pull Off a Surprise This Earnings Season?
by Zacks Equity Research
PLMR's second-quarter earnings are likely to have benefited from solid premium retention rates and higher yields on invested assets.
Earnings Preview: Oscar Health, Inc. (OSCR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Oscar Health (OSCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Cboe Global Pull Off a Surprise This Earnings Season?
by Zacks Equity Research
CBOE's Q2 results are likely to reflect solid index options growth, higher transaction and clearing fees, access and capacity fees, market data fees and regulatory fees.
What's in Store for Intercontinental Exchange This Earnings Season?
by Zacks Equity Research
ICE's Q2 results are likely to reflect strong index business, higher cash equities volume, increased origination technology revenues, and growth in pricing.
Assurant (AIZ) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Assurant (AIZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Willis Towers Set to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
WTW's Q2 performance is likely to have benefited from geographic expansion, strong client retention, and new business activity.
What's in the Cards for Arthur J. Gallagher This Earnings Season?
by Zacks Equity Research
AJG's Q2 results are likely to reflect solid retention, strategic acquisitions, improved investment income, as well as higher renewal premiums.
Can Hartford Beat Q2 Earnings Estimates on Growing Premiums?
by Zacks Equity Research
HIG eyes another earnings beat, fueled by premium growth and stronger Personal Insurance results in the second quarter.
Is a Beat in the Cards for Everest Group This Earnings Season?
by Zacks Equity Research
EG's Q2 results are likely to reflect higher earned premiums and higher income from fixed maturity investments, offset by higher expenses.
PRU Gears Up to Report Q2 Earnings: Here's What to Expect
by Zacks Equity Research
Prudential Financial's Q2 results are likely to reflect a favorable reserve experience and solid investment performance, offset by higher expenses.
What's in the Cards for Brown & Brown This Earnings Season?
by Zacks Equity Research
BRO's second-quarter 2025 results are likely to reflect organic revenue growth, acquisitions, and improved underwriting results.
Principal Financial to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
PFG's Q2 results are likely to reflect favorable underwriting experience as well as growth in the business and higher average invested assets.
Marsh & McLennan Q2 Earnings Beat on Risk and Insurance Strength
by Zacks Equity Research
MMC posts strong Q2 with EPS up 11% and revenues up 12%, fueled by robust growth in Risk and Insurance Services.
Marsh & McLennan Q2 Preview: Will Cost Pressures Weigh on Results?
by Zacks Equity Research
MMC's Q2 results are likely to reflect growth in Risk and Insurance Services and Consulting, but rising costs could weigh on margins.
AIZ Stock Trading at a Discount to Industry at 1.85X: Time to Hold?
by Zacks Equity Research
Assurant rides on growth in capital-light businesses, Connected Living, and Global Housing, supported by solid cash flow and strategic capital deployment.
Can Assurant and Plug Elevate the Pre-Owned Tech Experience?
by Zacks Equity Research
AIZ teams up with Plug to scale device protection, cut e-waste, and tap new growth in the booming pre-owned tech market.
Will Assurant (AIZ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Assurant (AIZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Radian Hits 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
Why Is Assurant (AIZ) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AIZ Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Assurant rides on growth in capital-light businesses, Connected Living, and Global Housing, supported by solid cash flow and strategic capital deployment.
Radian Group Near 52-Week High: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.